These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2081686)
21. Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study. Likosky WH; Fireman B; Elmore R; Eno G; Gale K; Goode GB; Ikeda K; Laster J; Mosher C; Rozance J J Neurol Neurosurg Psychiatry; 1991 Dec; 54(12):1055-60. PubMed ID: 1783915 [TBL] [Abstract][Full Text] [Related]
22. Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis. Gobbini MI; Smith ME; Richert ND; Frank JA; McFarland HF J Neuroimmunol; 1999 Sep; 99(1):142-9. PubMed ID: 10496187 [TBL] [Abstract][Full Text] [Related]
23. Long-lasting effects of cyclophosphamide on lymphocytes in peripheral blood and spinal fluid. Uitdehaag BM; Nillesen WM; Hommes OR Acta Neurol Scand; 1989 Jan; 79(1):12-7. PubMed ID: 2784607 [TBL] [Abstract][Full Text] [Related]
24. Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years. Gonsette RE; Demonty L; Delmotte P J Neurol; 1977 Feb; 214(3):173-81. PubMed ID: 65452 [TBL] [Abstract][Full Text] [Related]
25. Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies. Dawson DM; Carter JL; Hafler DA; Weiner HL Riv Neurol; 1987; 57(2):88-91. PubMed ID: 3039645 [TBL] [Abstract][Full Text] [Related]
26. Plasmapheresis with immunosuppressive drug therapy in progressive multiple sclerosis. A pilot study. Khatri BO; Koethe SM; McQuillen MP Arch Neurol; 1984 Jul; 41(7):734-8. PubMed ID: 6234867 [TBL] [Abstract][Full Text] [Related]
27. Follow-up study of MS patients treated with high-dose intravenous methylprednisolone. Frequin ST; Lamers KJ; Barkhof F; Borm GF; Hommes OR Acta Neurol Scand; 1994 Aug; 90(2):105-10. PubMed ID: 7801735 [TBL] [Abstract][Full Text] [Related]
28. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. Hauser SL; Dawson DM; Lehrich JR; Beal MF; Kevy SV; Propper RD; Mills JA; Weiner HL N Engl J Med; 1983 Jan; 308(4):173-80. PubMed ID: 6294517 [TBL] [Abstract][Full Text] [Related]
29. Effect of intensive immunosuppression on the course of chronic progressive multiple sclerosis. Hommers OR; Lamers KJ; Reekers P J Neurol; 1980; 223(3):177-90. PubMed ID: 6157011 [TBL] [Abstract][Full Text] [Related]
30. Immunological monitoring and clinical evaluation in cyclophosphamide-treated progressive multiple sclerosis patients. Salmaggi A; Milanese C; Eoli M; La Mantia L; Nespolo A; Dufour A Int J Neurosci; 1994 Jun; 76(3-4):305-12. PubMed ID: 7960486 [TBL] [Abstract][Full Text] [Related]